Citation Tools

Download PDFPDF

Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma

Download to a citation manager

Cite this article as:
Jamal R, Lapointe R, Cocolakis E, et al
Peripheral and local predictive immune signatures identified in a phase II trial of ipilimumab with carboplatin/paclitaxel in unresectable stage III or stage IV melanoma